Crossmark

Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries

Published Online: 2022-10-11

Published Print: 2023-09

Authors

Efthymiadou, Olina https://orcid.org/0000-0001-9018-7144
License Information

Text and Data Mining valid from 2022-10-11

Version of Record valid from 2022-10-11
More Information

Article History

Received: 1 February 2022

Accepted: 2 September 2022

First Online: 11 October 2022

Declarations

:

: The author received no specific funding for this work and declares no conflict of interest.

Document is current